The European Association for the Study of Obesity (EASO) will integrate its newly developed, GRADE-based framework for individualized pharmacological treatment of obesity into clinical guidelines and training initiatives. This adoption, confirmed by a consensus among expert panel members, is expected to standardize and enhance the quality of obesity treatment across clinical settings, minimizing risks while addressing the intricate nature of obesity management.